Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. | Third ...
Thursday’s meeting marked the last meeting of the year for the Texas A&M Board of Regents. At the meeting, the board approved a few such as a revision to an academic policy and a new course audit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback